Neuroscience-Informed Treatments

Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al.: Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018; 391:1683–1692Crossref, Google Scholar

Borrione L, Moffa AH, Martin D, et al.: Transcranial direct current stimulation in the acute depressive episode: a systematic review of current knowledge. J ECT 2018; 34:153–163Crossref, Google Scholar

Canuso CM, Singh JB, Fedgchin M, et al: Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry 2018; 175:620–630Google Scholar

Dougherty DD, Brennan BP, Stewart SE, et al.: Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review. JAMA Psychiatry 2018; 75:1081–1087Crossref, Google Scholar

Gandal MJ, Haney JR, Parikshak NN, et al: Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 2018; 359:693–697Google Scholar

Grazioli S, Mauri M, Crippa A, et al.: Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker? J Affect Disord 2018; 244:100–106Crossref, Google Scholar

Grunebaum MF, Galfalvy HC, Choo TH, et al.: Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 2018; 175:327–335Crossref, Google Scholar

Loo CK, Husain MM, McDonald WM, et al.: International randomized-controlled trial of transcranial direct current stimulation in depression. Brain Stimul 2018; 11:125–133Crossref, Google Scholar

Martin DM, Moffa A, Nikolin S, et al.: Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: an individual patient data meta-analysis of randomised, sham-controlled trials. Neurosci Biobehav Rev 2018; 90:137–145Crossref, Google Scholar

Marwood L, Wise T, Perkins AM, et al.: Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety. Neurosci Biobehav Rev 2018; 95:61–72Crossref, Google Scholar

McClintock SM, Reti IM, Carpenter LL, et al.: Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry 2018; 79:35–48Crossref, Google Scholar

Moffa AH, Brunoni AR, Nikolin S, et al.: Transcranial direct current stimulation in psychiatric disorders: a comprehensive review. Psychiatr Clin North Am 2018; 41:447–463Crossref, Google Scholar

Nemeroff CB: Ketamine: quo vadis? Am J Psychiatry 2018; 175:297–299Crossref, Google Scholar

Pereira LP, Köhler CA, Stubbs B, et al.: Imaging genetics paradigms in depression research: systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2018; 86:102–113Crossref, Google Scholar

Ryan KM, McLoughlin DM: From molecules to mind: mechanisms of action of electroconvulsive therapy. Acta Psychiatr Scand 2018; 138:177–179Google Scholar

Sanacora G, Katz R: Ketamine: a review for clinicians. Focus 2018; 16:243–250Link, Google Scholar

Sestan N, State MW: Lost in translation: traversing the complex path from genomics to therapeutics in autism spectrum disorder. Neuron 2018; 100:406–423Crossref, Google Scholar

Short B, Fong J, Galvez V, et al.: Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry 2018; 5:65–78Crossref, Google Scholar

Stevens MC, Pearlson GD, Calhoun VD, et al.: Functional neuroimaging evidence for distinct neurobiological pathways in attention-deficit/hyperactivity disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2018; 3:675–685Crossref, Google Scholar

Taylor SF, Ho SS, Abagis T, et al.: Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression. J Affect Disord 2018; 232:143–151Crossref, Google Scholar

Tolmeijer E, Kumari V, Peters E, et al.: Using fMRI and machine learning to predict symptom improvement following cognitive behavioural therapy for psychosis. Neuroimage Clin 2018; 20:1053–1061Crossref, Google Scholar

Volkow ND, Boyle M: Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry 2018; 175:729–740Crossref, Google Scholar

Antal A, Alekseichuk I, Bikson M, et al.: Low intensity transcranial electric stimulation: safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol 2017; 128:1774–1809Crossref, Google Scholar

Brunoni AR, Moffa AH, Sampaio-Junior B, et al.: Trial of electrical direct-current therapy versus escitalopram for depression. N Engl J Med 2017; 376:2523–2533Crossref, Google Scholar

Drysdale AT, Grosenick L, Downar J, et al.: Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 2017; 23:28–38Crossref, Google Scholar

Ross DA, Arbuckle MR, Travis MJ, et al.: An integrated neuroscience perspective on formulation and treatment planning for posttraumatic stress disorder: an educational review. JAMA Psychiatry 2017; 74:407–415Crossref, Google Scholar

Philip NS, Nelson BG, Frohlich F, et al.: Low-intensity transcranial current stimulation in psychiatry. Am J Psychiatry 2017; 174:628–639Crossref, Google Scholar

Sanacora G, Frye MA, McDonald W, et al.: A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 2017; 74:399–405Crossref, Google Scholar

Ballard ED, Ionescu DF, Vande Voort JL, et al.: Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res 2014; 58:161–166Crossref, Google Scholar

Berman RM, Cappiello A, Anand A, et al.: Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47:351–354Crossref, Google Scholar

Bikson M, Grossman P, Thomas C, et al.: Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimul 2016; 9:641–661Crossref, Google Scholar

Brunoni AR, Valiengo L, Baccaro A, et al.: The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013; 70:383–391Crossref, Google Scholar

Diazgranados N, Ibrahim L, Brutsche NE, et al.: A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67:793–802Crossref, Google Scholar

Dichter GS, Felder JN, Petty C, et al.: The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry 2009; 66:886–897Crossref, Google Scholar

Haskett RF: Electroconvulsive therapy’s mechanism of action: neuroendocrine hypotheses. J ECT 2014; 30:107–110Crossref, Google Scholar

Insel TR, Quirion R: Psychiatry as a clinical neuroscience discipline. JAMA 2005; 294:2221–2224Crossref, Google Scholar

Jelovac A, Kolshus E, McLoughlin DM: Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology 2013; 38:2467–2474Crossref, Google Scholar

Kellner CH, Greenberg RM, Murrough JW, et al.: ECT in treatment-resistant depression. Am J Psychiatry 2012; 169:1238–1244Crossref, Google Scholar

Kellner CH, Knapp RG, Petrides G, et al.: Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006; 63:1337–1344Crossref, Google Scholar

Kirov G, Ebmeier KP, Scott AI, et al.: Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry 2008; 193:152–155Crossref, Google Scholar

Lebowitz MS, Ahn WK: Emphasizing malleability in the biology of depression: durable effects on perceived agency and prognostic pessimism. Behav Res Ther 2015; 71:125–130Crossref, Google Scholar

Lisanby SH: Electroconvulsive therapy for depression. N Engl J Med 2007; 357:1939–1945Crossref, Google Scholar

Lisanby SH, Luber B, Schlaepfer TE, et al.: Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28:1852–1865Crossref, Google Scholar

Petrides G, Malur C, Braga RJ, et al: Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study. Am J Psychiatry 2015; 172:52–58Google Scholar

Semkovska M, McLoughlin DM: Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010; 68:568–577Crossref, Google Scholar

Skolnick P, Layer RT, Popik P, et al.: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 1996; 29:23–26Crossref, Google Scholar

Zanos P, Moaddel R, Morris PJ, et al.: NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016; 533:481–486Crossref, Google Scholar

Zarate CA Jr, Singh JB, Carlson PJ, et al.: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856–864Crossref, Google Scholar